
Collaboration Between Nordic University Hospitals
Tisdag 5 maj 2026 13:00 - 13:40 F3
Föreläsare: Boubou Hallberg, Stefan Jovinge, Rune Holdt, Kjetil TaskénModerator: Nasim Farrokhnia
Spår: Nordic cooperation for the life science of the future
No single institution can go it alone anymore. Nordic university hospitals are increasingly reaching across borders - sharing experiences, building partnerships, and recognising that only together can we create healthcare that is truly sustainable and robust. The Nordic countries hold a unique global asset: the world's most complete health registries, high public trust, and 28 million citizens whose data could drive the next generation of treatments and care. But realising this potential demands more than good intentions - it requires committed collaboration between hospitals, industry, and policymakers. This session brings together leaders from across the Nordic region to explore what that collaboration looks like in practice, and what it will take to turn shared ambition into shared impact.
Seminarietyp
Live + på plats
Konferens
Vitalis
Föreläsare
Boubou Hallberg Föreläsare
CEO of Sahlgrenska University Hospital in Göteborg, Sweden
Sahlgrenska University Hospital
Dr. Boubou Hallberg is CEO of Sahlgrenska University Hospital in Göteborg, Sweden, since August 2023. Dr. Hallberg is a pediatrician and specialist in neonatology. He has previously served as operations manager and chief physician at Karolinska University Hospital in Stockholm, as well as CEO and vice president in the United Arab Emirates for the healthcare group GHP International.
Stefan Jovinge Föreläsare
Prof Président of Research, Education, Development and Innovation
Skåne University Hospital
Prof Intensive Care Cardiology, Lund University., Stanford University.
Life Science advisor to the Swedish Government
Vice Chairman TRAIN Europe
Rune Holdt Föreläsare
Director for Research & Innovation
Rigshospitalet&Co-director BETA HEALTH
Rune Holdt is a senior executive with a proven record in leading innovation, transformation and complex programmes across the public healthcare system. He currently serves as Co-Director of BETA.HEALTH and Director for Research & Innovation at Rigshospitalet (Copenhagen University Hospital), operating at the intersection of clinical practice, research, innovation and system-level governance.
Rune has a strong track record in building and scaling innovation infrastructures, spanning early-stage research and clinical translation through procurement, implementation and large-scale adoption in hospital settings. He has led national and cross-regional initiatives in complex organisational environments, established sustainable governance and operating models, and worked closely with hospital leadership, regions, industry partners and policy actors to embed innovation as a core task within the healthcare system.
Kjetil Taskén Föreläsare
Head of Institute, Professor, MD, PhD
Oslo University Hospital
Kjetil Taskén (M.D., Ph.D.) was appointed Professor of Medicine at University of Oslo (UiO) in 2001 and has since 2018 served as Head of the Institute of Cancer Research, Oslo University Hospital (OUH) Comprehensive Cancer Centre where he is also Group Leader for the Cell Signaling and Immune Regulation Group in the Dept. of Cancer Immunology. He was the Director of the Biotechnology Centre of Oslo, UiO, from 2003 to 2016 and the founding Director of Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, UiO, where he served from 2008 to 2018.
Dr. Taskén has been key in building Norway's national cancer precision medicine initiative, now coordinates the EU Cancer Mission PRIME-ROSE project for DRUP-like clinical trials across Europe and leads the Work Package on treatment in the Joint Action for Precision Cancer Medicine that started end 2025. He has authored>300 publications and is an inventor of >20 patents (h-index >73). He won the King Olav V’s Prize for Cancer Research in 2016, the University of Oslo Innovation Prize in 2023, the Oslo University Hospital Excellent Researcher Award in 2024, and was Vice-President of the Norwegian Academy of Science and Letters 2023-25. Current research is in tumor immune evasion mechanisms and functional precision medicine for different solid and blood cancers.
Nasim Farrokhnia Moderator
läkare (specialist i internmedicin), medicine doktor (PhD) och MBA
eHälsoläkarföreningen
Nasim Bergman Farrokhnia is a seasoned healthcare executive with extensive experience in internal medicine and digital healthcare innovation. Currently part of Microsoft’s Global Healthcare and Life Sciences team, she is focused on digital transformation in healthcare and has contributed significantly to various healthcare organizations in Sweden.
Professionally, Farrokhnia has held leadership roles in notable digital healthcare providers such as Mindler and Kry/Livi, overseeing quality and research initiatives while expanding services in primary care psychiatry and digital healthcare. She holds a PhD from Uppsala University and has been recognized as one of the top influencers in Swedish tech. Farrokhnia is also a co-founder of a national research network on digital healthcare services and serves in various thought leadership roles within the healthcare sector.